GlassScriptPhysician profile
Matthew R Fultz
NPI 1619235876
$3,235.96
in general payments reported to CMS, 2019-2025
14 companies · $2,462 in 2025
The $2,462 reported for 2025 was more than what 78% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.20 · 2022: $372 · 2023: $257 · 2024: $115 · 2025: $2,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $760 · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $759.78 |
| Food and Beverage | $574.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,397.92 | 2023-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $305.33 | 2022-2024 | Advantagerib |
| Access Pro Medical, LLC | $89.42 | 2023 | Matriderm |
| Integra Lifesciences Corporation | $75.12 | 2022 | |
| Ethicon US, LLC | $58.28 | 2023-2024 | Echelon; Endopath, Vistaseal, Prolene |
| Kls-Martin L.P. | $52.60 | 2025 | |
| Acera Surgical, INC. | $51.44 | 2024-2025 | Restrata Wound Matrix |
| Mimedx Group, INC. | $49.90 | 2024-2025 | |
| Polynovo North America LLC | $35.67 | 2022-2025 | Novosorb Btm |
| Prytime Medical Devices, INC. | $30.20 | 2019 | |
| Edwards Lifesciences Corporation | $26.89 | 2024 | Hemosphere |
| Axogen | $21.68 | 2025 | |
| Medtronic, INC. | $21.23 | 2023 | Signia |
| Davol INC. | $20.28 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.